Elacestrant

CHEMBL4297509 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

458.6 g/mol

LogP

6.3

Phase

4

This oral medication blocks estrogen receptors in breast cancer cells, slowing or stopping tumor growth in certain hormone receptor-positive cancers. It is often used when other hormonal therapies have stopped working.

Masse moléculaire

458,6000 g/mol

LogP

6,30

TPSA

44,70 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Non-Small Cell Lung Cancer Breast Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1

InChI

InChI=1S/C30H38N2O2/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3/t26-/m1/s1

Molecular Formula

C30H38N2O2

HBD / HBA

2 / 4

Liaisons Rotatives

10

Atomes Lourds

34

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This oral medication blocks estrogen receptors in breast cancer cells, slowing or stopping tumor growth in certain hormone receptor-positive cancers. It is often used when other hormonal therapies have stopped working.

Yes, Elacestrant is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297509. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23642301. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Elacestrant sur PillFYI

Structure

Données Clés

Formule: C30H38N2O2
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.